Origin is building a platform that enables the creation of many decentralized marketplaces, allowing buyers and sellers to connect and transact directly on the blockchain. The company is building a set of protocols, developer libraries, and a decentralized application using the Ethereum blockchain and IPFS, with an initial focus on disrupting sharing economy marketplaces. Origin's mission is to reduce or remove transaction fees, promote open and transparent commerce, redistribute value more fairly to buyers and sellers, and empower the 2 billion currently unbanked individuals around the world to participate in digital marketplaces.

Minerva is the world's first reverse merchant processor. We pay transaction fees to approved businesses integrated within the Minerva economy, we don't charge them. Minerva is a platform designed to incentivize the adoption of its OWL token with a new and disruptive economic model.

Verifier is an innovative technology designed to verify identity, events, deals, and any other kind of data. This is a blockchain based solution that verifies data quickly, accurately, trustworthy, and securely.

CoinMarketFeed is world’s crypto social network. Connect with thousands of crypto traders and blockchain enthusiasts, Access real time cryptocurrency data, news and alerts. Buy price predictions directly from the best crypto traders globally or invest directly into their smart portfolio.

UNCHAINET connects underutilized server resources with clients who need them. Our blockchain protocols govern the network, align provider incentives with computing resource quality giving choices and transparency to the cloud client market.

MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.